Literature DB >> 25202017

Antimicrobial effects of helix D-derived peptides of human antithrombin III.

Praveen Papareddy1, Martina Kalle2, Ravi K V Bhongir3, Matthias Mörgelin3, Martin Malmsten4, Artur Schmidtchen5.   

Abstract

Antithrombin III (ATIII) is a key antiproteinase involved in blood coagulation. Previous investigations have shown that ATIII is degraded by Staphylococcus aureus V8 protease, leading to release of heparin binding fragments derived from its D helix. As heparin binding and antimicrobial activity of peptides frequently overlap, we here set out to explore possible antibacterial effects of intact and degraded ATIII. In contrast to intact ATIII, the results showed that extensive degradation of the molecule yielded fragments with antimicrobial activity. Correspondingly, the heparin-binding, helix D-derived, peptide FFFAKLNCRLYRKANKSSKLV (FFF21) of human ATIII, was found to be antimicrobial against particularly the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa. Fluorescence microscopy and electron microscopy studies demonstrated that FFF21 binds to and permeabilizes bacterial membranes. Analogously, FFF21 was found to induce membrane leakage of model anionic liposomes. In vivo, FFF21 significantly reduced P. aeruginosa infection in mice. Additionally, FFF21 displayed anti-endotoxic effects in vitro. Taken together, our results suggest novel roles for ATIII-derived peptide fragments in host defense.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Antimicrobial; Antithrombin (AT); Antithrombin iii; Bacteria; Heparin; Membrane; Peptide; Sepsis

Mesh:

Substances:

Year:  2014        PMID: 25202017      PMCID: PMC4207992          DOI: 10.1074/jbc.M114.570465

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli.

Authors:  M C Minnema; A C Chang; P M Jansen; Y T Lubbers; B M Pratt; B G Whittaker; F B Taylor; C E Hack; B Friedman
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

2.  Degradation of antiproteinases, complement and fibronectin in chronic leg ulcers.

Authors:  A Schmidtchen
Journal:  Acta Derm Venereol       Date:  2000-05       Impact factor: 4.437

3.  The thrombin antagonist hirudin fails to inhibit endotoxin-induced leukocyte/endothelial cell interaction and microvascular perfusion failure.

Authors:  J N Hoffmann; B Vollmar; D Inthorn; F W Schildberg; M D Menger
Journal:  Shock       Date:  2000-11       Impact factor: 3.454

Review 4.  Host defense peptides and their antimicrobial-immunomodulatory duality.

Authors:  Lars Steinstraesser; Ursula Kraneburg; Frank Jacobsen; Sammy Al-Benna
Journal:  Immunobiology       Date:  2010-08-19       Impact factor: 3.144

5.  LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature.

Authors:  Anne M van der Does; Henry Beekhuizen; Bep Ravensbergen; Tim Vos; Tom H M Ottenhoff; Jaap T van Dissel; Jan W Drijfhout; Pieter S Hiemstra; Peter H Nibbering
Journal:  J Immunol       Date:  2010-07-07       Impact factor: 5.422

6.  Proteolytic activation transforms heparin cofactor II into a host defense molecule.

Authors:  Martina Kalle; Praveen Papareddy; Gopinath Kasetty; Douglas M Tollefsen; Martin Malmsten; Matthias Mörgelin; Artur Schmidtchen
Journal:  J Immunol       Date:  2013-05-08       Impact factor: 5.422

7.  Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood.

Authors:  P J Souter; S Thomas; A R Hubbard; S Poole; J Römisch; E Gray
Journal:  Crit Care Med       Date:  2001-01       Impact factor: 7.598

8.  Engineering D-helix of antithrombin in alpha-1-proteinase inhibitor confers antiinflammatory properties on the chimeric serpin.

Authors:  L Yang; P Dinarvand; S H Qureshi; A R Rezaie
Journal:  Thromb Haemost       Date:  2014-02-13       Impact factor: 5.249

9.  Proteolysis of human thrombin generates novel host defense peptides.

Authors:  Praveen Papareddy; Victoria Rydengård; Mukesh Pasupuleti; Björn Walse; Matthias Mörgelin; Anna Chalupka; Martin Malmsten; Artur Schmidtchen
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

10.  Highly selective end-tagged antimicrobial peptides derived from PRELP.

Authors:  Martin Malmsten; Gopinath Kasetty; Mukesh Pasupuleti; Jan Alenfall; Artur Schmidtchen
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

View more
  10 in total

1.  Aggregation of thrombin-derived C-terminal fragments as a previously undisclosed host defense mechanism.

Authors:  Jitka Petrlova; Finja C Hansen; Mariena J A van der Plas; Roland G Huber; Matthias Mörgelin; Martin Malmsten; Peter J Bond; Artur Schmidtchen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-04       Impact factor: 11.205

2.  Antimicrobial Peptide JH-3 Effectively Kills Salmonella enterica Serovar Typhimurium Strain CVCC541 and Reduces Its Pathogenicity in Mice.

Authors:  Lei Wang; Xueqin Zhao; Xiaojing Xia; Chunling Zhu; Wanhai Qin; Yanzhao Xu; Bolin Hang; Yawei Sun; Shijun Chen; Huihui Zhang; Jinqing Jiang; Jianhe Hu; Hanna Fotina; Gaiping Zhang
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

3.  Antithrombin: An anticoagulant, anti-inflammatory and antibacterial serpin.

Authors:  Alireza R Rezaie; Hemant Giri
Journal:  J Thromb Haemost       Date:  2020-03       Impact factor: 5.824

Review 4.  Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions.

Authors:  Markus Huber-Lang; Kristina N Ekdahl; Rebecca Wiegner; Karin Fromell; Bo Nilsson
Journal:  Semin Immunopathol       Date:  2017-09-12       Impact factor: 9.623

Review 5.  Antithrombin and Its Role in Host Defense and Inflammation.

Authors:  Christine Schlömmer; Anna Brandtner; Mirjam Bachler
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

Review 6.  Anticoagulant and signaling functions of antithrombin.

Authors:  Alireza R Rezaie; Hemant Giri
Journal:  J Thromb Haemost       Date:  2020-09-09       Impact factor: 16.036

7.  Vertebrate TFPI-2 C-terminal peptides exert therapeutic applications against Gram-negative infections.

Authors:  Gopinath Kasetty; Emanuel Smeds; Emelie Holmberg; Louise Wrange; Selvi Adikesavan; Praveen Papareddy
Journal:  BMC Microbiol       Date:  2016-06-27       Impact factor: 3.605

Review 8.  Immunohaemostasis: a new view on haemostasis during sepsis.

Authors:  Xavier Delabranche; Julie Helms; Ferhat Meziani
Journal:  Ann Intensive Care       Date:  2017-12-02       Impact factor: 6.925

9.  An ecoimmunological approach to study evolutionary and ancient links between coagulation, complement and Innate immunity.

Authors:  Praveen Papareddy; Gopinath Kasetty; Saud Alyafei; Emanuel Smeds; Outi M H Salo-Ahen; Stefan R Hansson; Arne Egesten; Heiko Herwald
Journal:  Virulence       Date:  2018-12-31       Impact factor: 5.882

Review 10.  Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug-resistant Gram-negatives.

Authors:  María Escobar-Salom; Gabriel Torrens; Elena Jordana-Lluch; Antonio Oliver; Carlos Juan
Journal:  Biol Rev Camb Philos Soc       Date:  2022-01-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.